Use of a clinical pathway to manage unsuspected radiographic findings

William E. Holden, David Lewinsohn, Molly Osborne, Chris Griffin, Ann Spencer, Carol Duncan, Mark E. Deffebach

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Study objectives: To describe our 5-year experience with a clinical pathway used to ensure the timely communication and evaluation of unsuspected radiologic findings (URFs) noted on clinically requested chest imaging. Design: Prospective data collection on clinical practice. Setting: Academically affiliated Veterans Affairs medical center. Participants: Pulmonary physicians, nurses, and radiologists. Results:. Over a period of 5 years, 1,629 URFs were referred to the pathway (from chest radiographs, 1,359 [83.4%]; from CT scans, 270 [16.6%]). Most URFs (78%) were nodules, with a specific diagnosis made in one third of URFs, and with a specific diagnosis thought to be clinically significant in another one third of URFs. The most common diagnosis was neoplasm, with over two thirds of these diagnoses being lung cancer. One third of lung cancers detected were either stage 1 or 2, with 1 in 17 of all URFs being stage IA lung cancer. The cost of the pathway was estimated at $28,600 per year. Conclusions: URFs noted on chest imaging are frequently clinically significant, and a systematic approach to managing URFs, such as a clinical pathway, can significantly improve care in a large teaching hospital.

Original languageEnglish (US)
Pages (from-to)1753-1760
Number of pages8
JournalChest
Volume125
Issue number5
DOIs
StatePublished - May 2004
Externally publishedYes

Fingerprint

Critical Pathways
Lung Neoplasms
Thorax
Veterans
Teaching Hospitals
Nurses
Communication
Physicians
Costs and Cost Analysis
Lung
Neoplasms

Keywords

  • Chest radiograph
  • Clinical pathway
  • Lung cancer
  • Lung nodule
  • Radiographic findings
  • Radiology
  • Radiology information systems

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Holden, W. E., Lewinsohn, D., Osborne, M., Griffin, C., Spencer, A., Duncan, C., & Deffebach, M. E. (2004). Use of a clinical pathway to manage unsuspected radiographic findings. Chest, 125(5), 1753-1760. https://doi.org/10.1378/chest.125.5.1753

Use of a clinical pathway to manage unsuspected radiographic findings. / Holden, William E.; Lewinsohn, David; Osborne, Molly; Griffin, Chris; Spencer, Ann; Duncan, Carol; Deffebach, Mark E.

In: Chest, Vol. 125, No. 5, 05.2004, p. 1753-1760.

Research output: Contribution to journalArticle

Holden, WE, Lewinsohn, D, Osborne, M, Griffin, C, Spencer, A, Duncan, C & Deffebach, ME 2004, 'Use of a clinical pathway to manage unsuspected radiographic findings', Chest, vol. 125, no. 5, pp. 1753-1760. https://doi.org/10.1378/chest.125.5.1753
Holden, William E. ; Lewinsohn, David ; Osborne, Molly ; Griffin, Chris ; Spencer, Ann ; Duncan, Carol ; Deffebach, Mark E. / Use of a clinical pathway to manage unsuspected radiographic findings. In: Chest. 2004 ; Vol. 125, No. 5. pp. 1753-1760.
@article{73e094aa594b41cf8e76b3f4c80ca555,
title = "Use of a clinical pathway to manage unsuspected radiographic findings",
abstract = "Study objectives: To describe our 5-year experience with a clinical pathway used to ensure the timely communication and evaluation of unsuspected radiologic findings (URFs) noted on clinically requested chest imaging. Design: Prospective data collection on clinical practice. Setting: Academically affiliated Veterans Affairs medical center. Participants: Pulmonary physicians, nurses, and radiologists. Results:. Over a period of 5 years, 1,629 URFs were referred to the pathway (from chest radiographs, 1,359 [83.4{\%}]; from CT scans, 270 [16.6{\%}]). Most URFs (78{\%}) were nodules, with a specific diagnosis made in one third of URFs, and with a specific diagnosis thought to be clinically significant in another one third of URFs. The most common diagnosis was neoplasm, with over two thirds of these diagnoses being lung cancer. One third of lung cancers detected were either stage 1 or 2, with 1 in 17 of all URFs being stage IA lung cancer. The cost of the pathway was estimated at $28,600 per year. Conclusions: URFs noted on chest imaging are frequently clinically significant, and a systematic approach to managing URFs, such as a clinical pathway, can significantly improve care in a large teaching hospital.",
keywords = "Chest radiograph, Clinical pathway, Lung cancer, Lung nodule, Radiographic findings, Radiology, Radiology information systems",
author = "Holden, {William E.} and David Lewinsohn and Molly Osborne and Chris Griffin and Ann Spencer and Carol Duncan and Deffebach, {Mark E.}",
year = "2004",
month = "5",
doi = "10.1378/chest.125.5.1753",
language = "English (US)",
volume = "125",
pages = "1753--1760",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "5",

}

TY - JOUR

T1 - Use of a clinical pathway to manage unsuspected radiographic findings

AU - Holden, William E.

AU - Lewinsohn, David

AU - Osborne, Molly

AU - Griffin, Chris

AU - Spencer, Ann

AU - Duncan, Carol

AU - Deffebach, Mark E.

PY - 2004/5

Y1 - 2004/5

N2 - Study objectives: To describe our 5-year experience with a clinical pathway used to ensure the timely communication and evaluation of unsuspected radiologic findings (URFs) noted on clinically requested chest imaging. Design: Prospective data collection on clinical practice. Setting: Academically affiliated Veterans Affairs medical center. Participants: Pulmonary physicians, nurses, and radiologists. Results:. Over a period of 5 years, 1,629 URFs were referred to the pathway (from chest radiographs, 1,359 [83.4%]; from CT scans, 270 [16.6%]). Most URFs (78%) were nodules, with a specific diagnosis made in one third of URFs, and with a specific diagnosis thought to be clinically significant in another one third of URFs. The most common diagnosis was neoplasm, with over two thirds of these diagnoses being lung cancer. One third of lung cancers detected were either stage 1 or 2, with 1 in 17 of all URFs being stage IA lung cancer. The cost of the pathway was estimated at $28,600 per year. Conclusions: URFs noted on chest imaging are frequently clinically significant, and a systematic approach to managing URFs, such as a clinical pathway, can significantly improve care in a large teaching hospital.

AB - Study objectives: To describe our 5-year experience with a clinical pathway used to ensure the timely communication and evaluation of unsuspected radiologic findings (URFs) noted on clinically requested chest imaging. Design: Prospective data collection on clinical practice. Setting: Academically affiliated Veterans Affairs medical center. Participants: Pulmonary physicians, nurses, and radiologists. Results:. Over a period of 5 years, 1,629 URFs were referred to the pathway (from chest radiographs, 1,359 [83.4%]; from CT scans, 270 [16.6%]). Most URFs (78%) were nodules, with a specific diagnosis made in one third of URFs, and with a specific diagnosis thought to be clinically significant in another one third of URFs. The most common diagnosis was neoplasm, with over two thirds of these diagnoses being lung cancer. One third of lung cancers detected were either stage 1 or 2, with 1 in 17 of all URFs being stage IA lung cancer. The cost of the pathway was estimated at $28,600 per year. Conclusions: URFs noted on chest imaging are frequently clinically significant, and a systematic approach to managing URFs, such as a clinical pathway, can significantly improve care in a large teaching hospital.

KW - Chest radiograph

KW - Clinical pathway

KW - Lung cancer

KW - Lung nodule

KW - Radiographic findings

KW - Radiology

KW - Radiology information systems

UR - http://www.scopus.com/inward/record.url?scp=2442625257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442625257&partnerID=8YFLogxK

U2 - 10.1378/chest.125.5.1753

DO - 10.1378/chest.125.5.1753

M3 - Article

C2 - 15136387

AN - SCOPUS:2442625257

VL - 125

SP - 1753

EP - 1760

JO - Chest

JF - Chest

SN - 0012-3692

IS - 5

ER -